CLINICAL_TRIALS
trial_result
· 2010-04-20
Clinical Trial Update: Molecular Profiling in Lung Cancer Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating molecular profiling in non-small cell lung cancer patients has completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer, Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2010-04-20